Valuation: Ind-Swift Laboratories Limited

Market Cap 11.4B 118M 104M 96.66M 88.7M 167M 169M 1.15B 448M 5.6B 444M 435M 19.37B P/E 2024
1.41x
P/E 2025 2.38x
Enterprise Value 7.13B 74.05M 65.04M 60.48M 55.5M 104M 106M 718M 281M 3.51B 278M 272M 12.12B EV / Sales 2024
0.14x
EV / Sales 2025 0.12x
Free-Float
40.72%
Yield 2024 *
-
Yield 2025 -
1 day+5.46%
1 week+2.53%
Current month+17.87%
1 month+16.88%
3 months+78.64%
6 months+124.17%
Current year+172.16%
1 week 217.77
Extreme 217.77
240.7
1 month 197.1
Extreme 197.1
248.45
Current year 87.25
Extreme 87.25
248.45
1 year 87.15
Extreme 87.15
248.45
3 years 68.72
Extreme 68.72
248.45
5 years 52.65
Extreme 52.65
248.45
10 years 15
Extreme 15
248.45
Manager TitleAgeSince
Chief Executive Officer 74 04/01/1995
Chief Executive Officer 43 15/06/2011
Director of Finance/CFO - 29/09/2018
Director TitleAgeSince
Director/Board Member 43 -
Chairman 74 -
Director/Board Member 35 23/03/2010
Date Insider Type Main position Quantity % Market Cap.
12/9/24 Sell

Chief Financial Officer

30,000 0.0508%
Change 5-day change 1-year change 3-year change Capi.($)
+5.46%+2.53%+129.16%+163.20% 205M
+1.68%+0.88%+15.95%+73.90% 48.36B
+1.52%+2.21%+61.55%+111.64% 35.8B
-0.09%-2.23%-10.34%+20.31% 11.83B
-0.05%-3.55%+13.07%+70.62% 11.48B
-0.93%-0.37%+37.53%+142.08% 9.01B
+0.18%+1.77%+47.40%-8.43% 6.99B
+1.29%-1.26%+12.73%+33.26% 6.7B
+0.18%-1.94%+2.41%+167.04% 6.42B
-7.92%-13.61%-33.87%-3.30% 5.3B
Average +0.13%-2.08%+27.56%+77.03% 14.21B
Weighted average by Cap. +0.67%-0.45%+25.47%+78.50%

Financials

2024 2025
Net sales 12.97B 135M 118M 110M 101M 190M 193M 1.31B 510M 6.38B 506M 495M 22.05B 5.62B 58.33M 51.23M 47.64M 43.72M 82.14M 83.41M 566M 221M 2.76B 219M 214M 9.55B
Net income 4.21B 43.71M 38.39M 35.7M 32.76M 61.56M 62.51M 424M 166M 2.07B 164M 161M 7.16B 2.5B 26.01M 22.84M 21.24M 19.49M 36.63M 37.19M 252M 98.56M 1.23B 97.64M 95.54M 4.26B
Net Debt -4.15B -43.13M -37.88M -35.23M -32.32M -60.73M -61.67M -418M -163M -2.04B -162M -158M -7.06B -4.27B -44.29M -38.9M -36.18M -33.2M -62.38M -63.34M -430M -168M -2.1B -166M -163M -7.25B
Logo Ind-Swift Laboratories Limited
Ind-Swift Laboratories Limited is an India-based company, which is engaged in the business of manufacturing active pharmaceutical ingredients (APIs), intermediates and formulations. The Company operates in the Pharmaceutical Business segment. It also focuses on manufacturing formulations. The Company’s products include APIs and Impurities. Its APIs therapeutic category includes Macrolide Antibiotic, Cardiovascular, Antihistaminic, Antidiabetic, Antipsyhotic, Bone Resorption Inhibitor, and Aromatase Inhibitor. Its products include Clarithromycin, Clarithromycin Coated Granules, Clarithromycin Citrate, Atorvastatin Calcium Crystalline, Atorvastatin Calcium Amorphous, Clopidogrel HCl, Ezetimibe, Ivabradine Oxalate, Ranolazine, Aripiprazole, Risedronate Sodium, Ropinirole HCl, Cinacalcet HCl, Letrozole, and Anastrozole. Its products under development include Sitagliptin Phosphate, Mirabegron, Bempedoic Acid, Lasmiditan, and Eltrombopag Olamine.
Employees
1,246
Date Price Change Volume
27/07/26 239.91 +5.46% 478,681
24/07/26 ₹227.49 +0.66% 447,383
23/07/26 ₹225.99 -3.04% 397,859
22/07/26 ₹233.07 -1.91% 447,639
21/07/26 ₹237.60 +1.54% 271,232
  1. Stock Market
  2. Stocks
  3. INDSWFTLAB Stock